2022 Q3 Form 10-Q Financial Statement

#000165495422011183 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $472.4K $741.5K
YoY Change -43.16% -36.15%
Cash & Equivalents $641.8K $950.1K
Short-Term Investments
Other Short-Term Assets $227.7K $258.4K
YoY Change -16.9% 13.39%
Inventory
Prepaid Expenses
Receivables $155.1K $89.59K
Other Receivables $0.00 $0.00
Total Short-Term Assets $855.3K $1.090M
YoY Change -38.42% -28.92%
LONG-TERM ASSETS
Property, Plant & Equipment $254.5K $298.2K
YoY Change -40.55% -36.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $254.5K $298.2K
YoY Change -40.55% -36.54%
TOTAL ASSETS
Total Short-Term Assets $855.3K $1.090M
Total Long-Term Assets $254.5K $298.2K
Total Assets $1.110M $1.388M
YoY Change -38.92% -30.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $104.7K $115.2K
YoY Change 301.46% -19.95%
Accrued Expenses $165.1K $166.6K
YoY Change -50.48% -52.35%
Deferred Revenue $431.9K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $5.000M
YoY Change
Total Short-Term Liabilities $867.3K $5.854M
YoY Change -86.23% 716.21%
LONG-TERM LIABILITIES
Long-Term Debt $5.000M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $196.6K $240.0K
YoY Change -46.16% -77.16%
Total Long-Term Liabilities $5.197M $240.0K
YoY Change -96.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $867.3K $5.854M
Total Long-Term Liabilities $5.197M $240.0K
Total Liabilities $6.064M $6.094M
YoY Change -15.87% -16.63%
SHAREHOLDERS EQUITY
Retained Earnings -$259.5M -$257.4M
YoY Change 3.27%
Common Stock $28.39K $28.39K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.954M -$4.707M
YoY Change
Total Liabilities & Shareholders Equity $1.110M $1.388M
YoY Change -38.92% -30.7%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Cash
Cash
372581 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
169337 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
58388 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
50304 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
855292 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
254544 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
342383 usd
CY2022Q2 us-gaap Assets
Assets
1109836 usd
CY2021Q4 us-gaap Assets
Assets
1048904 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
104748 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83942 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
15617 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
17646 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
165459 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
156986 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
149525 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
149525 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
431910 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
464162 usd
CY2022Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
0 usd
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
5000000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
867259 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5872261 usd
most Basic And Fully Diluted From Continuing Operations
BasicAndFullyDilutedFromContinuingOperations
-0.58
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1521179 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1403276 shares
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28389493 shares
CY2022Q2 us-gaap Cash
Cash
472434 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
202761 usd
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
most Basic And Fully Diluted From Continuing Operations
BasicAndFullyDilutedFromContinuingOperations
-0.40
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Central Index Key
EntityCentralIndexKey
0001113513
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 most Designated For Series A Convertible Preferred Shares
DesignatedForSeriesAConvertiblePreferredShares
1750000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1521179 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1403276 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28389493 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28389493 shares
CY2022Q1 most Annual Periods Discounted Cash Flows
AnnualPeriodsDiscountedCashFlows
P3Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32634
dei Entity Registrant Name
EntityRegistrantName
MOBILESMITH, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4439334
dei Entity Address Address Line1
EntityAddressAddressLine1
5400 Trinity Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 208
dei Entity Address City Or Town
EntityAddressCityOrTown
Raleigh
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27607
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
516-2413
CY2022Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
15000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
155133 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
80875 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
706521 usd
CY2022Q2 most Short Term Borrowings1
ShortTermBorrowings1
5000000 usd
CY2021Q4 most Short Term Borrowings1
ShortTermBorrowings1
0 usd
CY2022Q2 most Operating Lease Liability Current1
OperatingLeaseLiabilityCurrent1
196594 usd
CY2021Q4 most Operating Lease Liability Current1
OperatingLeaseLiabilityCurrent1
282534 usd
CY2022Q2 us-gaap Liabilities
Liabilities
6063853 usd
CY2021Q4 us-gaap Liabilities
Liabilities
6154795 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 most Designated For Series A Convertible Preferred Shares
DesignatedForSeriesAConvertiblePreferredShares
1750000 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
132459976 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
127162277 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28389493 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28389493 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
28390 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
28390 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
122056344 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
123015819 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-259498727 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-255312377 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-4954017 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5105891 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1109836 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1048904 usd
CY2022Q2 most Subscription And Support Revenue
SubscriptionAndSupportRevenue
295607 usd
CY2021Q2 most Subscription And Support Revenue
SubscriptionAndSupportRevenue
398358 usd
most Subscription And Support Revenue
SubscriptionAndSupportRevenue
625509 usd
most Subscription And Support Revenue
SubscriptionAndSupportRevenue
816343 usd
CY2022Q2 us-gaap Revenues
Revenues
295607 usd
CY2021Q2 us-gaap Revenues
Revenues
398358 usd
us-gaap Revenues
Revenues
625509 usd
us-gaap Revenues
Revenues
816343 usd
CY2022Q2 most Subscription And Support Revenue1
SubscriptionAndSupportRevenue1
148249 usd
CY2021Q2 most Subscription And Support Revenue1
SubscriptionAndSupportRevenue1
199944 usd
most Subscription And Support Revenue1
SubscriptionAndSupportRevenue1
271820 usd
most Subscription And Support Revenue1
SubscriptionAndSupportRevenue1
405247 usd
CY2022Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
0 usd
CY2021Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
0 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
0 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
9000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
148249 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
199944 usd
us-gaap Cost Of Revenue
CostOfRevenue
271820 usd
us-gaap Cost Of Revenue
CostOfRevenue
414247 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
147358 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
198414 usd
us-gaap Gross Profit
GrossProfit
353689 usd
us-gaap Gross Profit
GrossProfit
402096 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
343810 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
476147 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
721693 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1004441 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
997667 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
858571 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2064863 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1734237 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
801104 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
705489 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1633038 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1611373 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2142581 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2040207 usd
us-gaap Operating Expenses
OperatingExpenses
4419594 usd
us-gaap Operating Expenses
OperatingExpenses
4350051 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1995223 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1841793 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4065905 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3947954 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
72874 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
48075 usd
us-gaap Interest Expense
InterestExpense
120445 usd
us-gaap Interest Expense
InterestExpense
190540 usd
CY2022Q2 most Gains Losses On Extinguishment Of Debt Other
GainsLossesOnExtinguishmentOfDebtOther
0 usd
CY2021Q2 most Gains Losses On Extinguishment Of Debt Other
GainsLossesOnExtinguishmentOfDebtOther
0 usd
most Gains Losses On Extinguishment Of Debt Other
GainsLossesOnExtinguishmentOfDebtOther
0 usd
most Gains Losses On Extinguishment Of Debt Other
GainsLossesOnExtinguishmentOfDebtOther
542100 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
6507137 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
72874 usd
CY2021Q2 us-gaap Other Expenses
OtherExpenses
48075 usd
us-gaap Other Expenses
OtherExpenses
120445 usd
us-gaap Other Expenses
OtherExpenses
6155577 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2068097 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1889868 usd
us-gaap Net Income Loss
NetIncomeLoss
-4186350 usd
us-gaap Net Income Loss
NetIncomeLoss
-10103531 usd
CY2022Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2021Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
2597699 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2022Q2 most Deemed Dividends Preferred Stock Stock
DeemedDividendsPreferredStockStock
-979020 usd
CY2021Q2 most Deemed Dividends Preferred Stock Stock
DeemedDividendsPreferredStockStock
-1000000 usd
most Deemed Dividends Preferred Stock Stock
DeemedDividendsPreferredStockStock
-4443425 usd
most Deemed Dividends Preferred Stock Stock
DeemedDividendsPreferredStockStock
-6269401 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3047117 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2889868 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11227474 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16372932 usd
CY2022Q2 most Basic And Fully Diluted From Continuing Operations
BasicAndFullyDilutedFromContinuingOperations
-0.11
CY2021Q2 most Basic And Fully Diluted From Continuing Operations
BasicAndFullyDilutedFromContinuingOperations
-0.10
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28389493 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28389493 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28389493 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28389493 shares
us-gaap Net Income Loss
NetIncomeLoss
-4186350 usd
us-gaap Net Income Loss
NetIncomeLoss
-10103531 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
15000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
78120 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1638224 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1693608 usd
most Gain Of Debt Extinguishment Ppp Loan Forgiveness
GainOfDebtExtinguishmentPppLoanForgiveness
0 usd
most Gain Of Debt Extinguishment Ppp Loan Forgiveness
GainOfDebtExtinguishmentPppLoanForgiveness
-542100 usd
most Losses On Debt Extinguishments
LossesOnDebtExtinguishments
0 usd
most Losses On Debt Extinguishments
LossesOnDebtExtinguishments
6507137 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-89258 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-169727 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-8084 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-31020 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20806 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-129758 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-32252 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
27201 usd
most Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
87839 usd
most Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
83982 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-85940 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-79354 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6444 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
41747 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2633571 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2623695 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
542000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2700000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2761700 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2700000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3303700 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
66429 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
680005 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
575342 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
350923 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
641771 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1030928 usd
most Cash And Cash Equivalents1
CashAndCashEquivalents1
472434 usd
most Cash And Cash Equivalents1
CashAndCashEquivalents1
831191 usd
most Restricted Cash1
RestrictedCash1
169337 usd
most Restricted Cash1
RestrictedCash1
199737 usd
most Total Cash Cash Equivalents And Restricted Cash
TotalCashCashEquivalentsAndRestrictedCash
641771 usd
most Total Cash Cash Equivalents And Restricted Cash
TotalCashCashEquivalentsAndRestrictedCash
1030928 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
103080 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
102863 usd
us-gaap Interest Paid Net
InterestPaidNet
120454 usd
us-gaap Interest Paid Net
InterestPaidNet
97319 usd
most Recorded Discount Associated With Beneficial Conversion Feature On Issuance Of Series A Convertible Preferred Shares
RecordedDiscountAssociatedWithBeneficialConversionFeatureOnIssuanceOfSeriesAConvertiblePreferredShares
4443425 usd
most Recorded Discount Associated With Beneficial Conversion Feature On Issuance Of Series A Convertible Preferred Shares
RecordedDiscountAssociatedWithBeneficialConversionFeatureOnIssuanceOfSeriesAConvertiblePreferredShares
6269401 usd
most Issued Series A Preferred Shares Fair Valued At7660970 In Exchange For Carrying Value Of Debt Including Accrued Interest Premiums And Discounts Of1153833
IssuedSeriesAPreferredSharesFairValuedAt7660970InExchangeForCarryingValueOfDebtIncludingAccruedInterestPremiumsAndDiscountsOf1153833
0 usd
most Issued Series A Preferred Shares Fair Valued At7660970 In Exchange For Carrying Value Of Debt Including Accrued Interest Premiums And Discounts Of1153833
IssuedSeriesAPreferredSharesFairValuedAt7660970InExchangeForCarryingValueOfDebtIncludingAccruedInterestPremiumsAndDiscountsOf1153833
6507137 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2597699 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-7403220 usd
CY2021Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
886935 usd
CY2021Q1 most Exchange Of Debt For Series A Convertible Preferred Shares On January282021 Amount
ExchangeOfDebtForSeriesAConvertiblePreferredSharesOnJanuary282021Amount
7660970 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1761700 usd
CY2021Q1 most Beneficial Conversion Feature Recorded As A Result Of Issuance Of Series A Convertible Preferred Shares Of5269401
BeneficialConversionFeatureRecordedAsAResultOfIssuanceOfSeriesAConvertiblePreferredSharesOf5269401
5269401 usd
CY2021Q1 most Deemed Dividend To The Holders Of Series A Preferred Shares
DeemedDividendToTheHoldersOfSeriesAPreferredShares
-5269401 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8213663 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-5307278 usd
CY2021Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
806673 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000 usd
CY2021Q2 most Beneficial Conversion Feature Recorded As A Result Of Issuance Of Series A Convertible Preferred Shares Of5269401
BeneficialConversionFeatureRecordedAsAResultOfIssuanceOfSeriesAConvertiblePreferredSharesOf5269401
1000000 usd
CY2021Q2 most Deemed Dividend To The Holders Of Series A Preferred Shares Resulting From Amortization Of Discount Associated With The Beneficial Conversion Feature
DeemedDividendToTheHoldersOfSeriesAPreferredSharesResultingFromAmortizationOfDiscountAssociatedWithTheBeneficialConversionFeature
-1000000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1889868 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-5390473 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5105891 usd
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
817522 usd
CY2022Q1 most Issuance Of Series A Convertible Preferred Shares For Cash Amount
IssuanceOfSeriesAConvertiblePreferredSharesForCashAmount
1700000 usd
CY2022Q1 most Stockissueddividend On Series A Convertible Preferred Shares Amount
StockissueddividendOnSeriesAConvertiblePreferredSharesAmount
0 usd
CY2022Q1 most Beneficial Conversion Feature Recorded As A Result Of Issuance Of Series A Convertible Preferred Shares Of5269401
BeneficialConversionFeatureRecordedAsAResultOfIssuanceOfSeriesAConvertiblePreferredSharesOf5269401
3465405 usd
CY2022Q1 most Deemed Dividend To The Holders Of Series A Preferred Shares Resulting From Amortization Of Discount Associated With The Beneficial Conversion Feature
DeemedDividendToTheHoldersOfSeriesAPreferredSharesResultingFromAmortizationOfDiscountAssociatedWithTheBeneficialConversionFeature
-3465405 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2118253 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4706622 usd
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
820702 usd
CY2022Q2 most Exchange Of Debt For Series A Convertible Preferred Shares
ExchangeOfDebtForSeriesAConvertiblePreferredShares
0 usd
CY2022Q2 most Issuance Of Series A Convertible Preferred Shares For Cash Amount
IssuanceOfSeriesAConvertiblePreferredSharesForCashAmount
1000000 usd
CY2022Q2 most Issuance Of Dividend On Series A Convertible Preferred Shares
IssuanceOfDividendOnSeriesAConvertiblePreferredShares
0 usd
CY2022Q2 most Beneficial Conversion Feature Recorded As A Result Of Issuance Of Series A Convertible Preferred Shares Of5269401
BeneficialConversionFeatureRecordedAsAResultOfIssuanceOfSeriesAConvertiblePreferredSharesOf5269401
699300 usd
CY2022Q2 most Deemed Dividend To The Holders Of Series A Preferred Shares Resulting From Amortization Of Discount Associated With The Beneficial Conversion Feature
DeemedDividendToTheHoldersOfSeriesAPreferredSharesResultingFromAmortizationOfDiscountAssociatedWithTheBeneficialConversionFeature
-699300 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2068097 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-4954017 usd
CY2021Q2 most Total Billing
TotalBilling
501543 usd
most Revenue
Revenue
594703 usd
CY2022Q2 most Total Billing
TotalBilling
593257 usd
most Revenue
Revenue
625509 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10883300 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2021 most Aggregate Intrinsic Value Outstanding Beginning
AggregateIntrinsicValueOutstandingBeginning
9553832 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1774610 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
500000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.55
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9608690 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.11
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y4M24D
most Aggregate Intrinsic Value Outstanding Ending
AggregateIntrinsicValueOutstandingEnding
12275437 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5462850 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.96
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M18D
most Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableIntrinsicValue
7786913 usd
CY2022Q2 most Closing Price Of The Common Stock
ClosingPriceOfTheCommonStock
3.39
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7161694 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y10M24D
CY2022Q1 most Fundamental Business Enterprise Value
FundamentalBusinessEnterpriseValue
39000000 usd
CY2022Q1 most Discount Rate On Trminal Value
DiscountRateOnTrminalValue
0.50 pure
CY2022Q1 most Number Of Shares Diluted
NumberOfSharesDiluted
72836053 shares
CY2022Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
1481552 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
The options are issued under standard Company terms: term of ten years, vesting over five years and exercise price at or above fair market value on the date of grant.
us-gaap Revenues
Revenues
816343 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
593257 usd
us-gaap Revenues
Revenues
625509 usd
CY2021Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
843543 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
103080 usd
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y9M29D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
102585 usd
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
205593 usd
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
68531 usd
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
376709 usd
CY2022Q2 most Imputed Interest
ImputedInterest
-30590 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
346119 usd
CY2022Q2 most Series A Preferred Stock Issued
SeriesAPreferredStockIssued
17483 shares
most Cash Proceeds From Issuance Of Series A Preferred Stock
CashProceedsFromIssuanceOfSeriesAPreferredStock
750000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2250000 shares

Files In Submission

Name View Source Status
0001654954-22-011183-index-headers.html Edgar Link pending
0001654954-22-011183-index.html Edgar Link pending
0001654954-22-011183.txt Edgar Link pending
0001654954-22-011183-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
most-20220630.xsd Edgar Link pending
most_10q.htm Edgar Link pending
most_ex311.htm Edgar Link pending
most_ex312.htm Edgar Link pending
most_ex321.htm Edgar Link pending
most_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
most-20220630_cal.xml Edgar Link unprocessable
most-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
most-20220630_lab.xml Edgar Link unprocessable
most-20220630_pre.xml Edgar Link unprocessable
most_10q_htm.xml Edgar Link completed